Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
DNA Capital is a global healthcare-focused investment firm founded in 2013. With a significant presence in both North America and Latin America, the firm partners with exceptional entrepreneurs to build transformative companies across various healthcare sectors, including healthtech, biotech, pharmaceutical services, and medical devices. DNA Capital leverages its deep industry expertise, extensive network, and operational capabilities to support its portfolio companies in achieving scalable growth and making a meaningful impact on healthcare delivery and innovation.
Serves as a central hub for DNA Capital's investment activities in Latin America, including deal origination, due diligence, portfolio company management, and fostering relationships within the regional healthcare and innovation ecosystem.
Modern office facilities situated in a prime business district, designed to foster collaboration, strategic planning, and engagement with the local market.
Characterized by a dynamic, entrepreneurial, and highly collaborative environment. The team is driven by a passion for advancing healthcare through innovation and a commitment to providing hands-on support to portfolio companies. Emphasis is placed on deep market analysis, strategic insights, and value creation.
Its São Paulo location is strategically important for tapping into Latin America's burgeoning healthcare market, accessing a vibrant pool of entrepreneurial talent, and capitalizing on co-investment opportunities within one of the region's largest financial and innovation centers.
DNA Capital operates with a focused global investment strategy in healthcare, primarily centered on North America and Latin America. Key operational offices in São Paulo, Brazil, and Miami, USA, are complemented by a strategic presence in San Francisco. This structure enables the firm to effectively source investment opportunities, conduct thorough due diligence, provide hands-on support to its diverse portfolio companies across these geographies, and connect with global healthcare innovation trends and investor networks.
Av. Brigadeiro Faria Lima, 3477 - Torre B - 12º andar - Itaim Bibi
São Paulo
SP
Brazil
Address: 200 S. Biscayne Blvd, Suite 2770, Miami, FL 33131
To identify and partner with high-growth healthcare companies in North America, leverage cross-border synergies with Latin American markets, and engage with U.S.-based limited partners and strategic collaborators.
Address: [Strategic presence; specific office address not publicly listed]
To facilitate deal sourcing, networking with entrepreneurs and venture partners, identify emerging technologies, and support portfolio companies with interests or operations on the West Coast.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, DNA Capital' leadership includes:
DNA Capital has been backed by several prominent investors over the years, including:
DNA Capital strengthened its team in the past 12 months with key strategic hires, including a new Partner and Head of Investor Relations, and an Operating Partner, enhancing its capabilities in investor relations and portfolio company support. No major publicly disclosed departures from the senior executive team were noted during this period.
Discover the tools DNA Capital uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
DNA Capital likely utilizes common professional email formats. Based on industry standards and observed patterns for similar firms, primary formats often include a combination of the employee's first name and last name, or first initial and last name.
first.last@dnacapital.com or firstinitiallast@dnacapital.com
Format
jane.doe@dnacapital.com or jdoe@dnacapital.com
Example
85%
Success rate
Business Wire • November 15, 2023
Jasper Health, an AI-powered cancer care navigation platform, announced a $25 million Series A extension funding round led by DNA Capital. This investment aims to help Jasper Health enhance its platform capabilities and expand its reach to more patients and healthcare providers....more
PR Newswire • June 20, 2023
Alinea Health, a company dedicated to improving access to specialized women's healthcare, secured a $6.2 million Series A funding round with DNA Capital as the lead investor. The funds are intended to support the expansion of Alinea Health's services and its operational footprint....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including DNA Capital, are just a search away.